Tourette Syndrome clinical trials at University of California Health
2 in progress, 1 open to eligible people
open to eligible people ages 6-18
This study is an international, multicenter, open-label, long term extension study evaluating the safety of ecopipam tablets for the treatment of children and adolescent subjects with Tourette Syndrome.
Sorry, accepting new patients by invitation only
This study examines circadian rhythms and morningness-eveningness preference in youth with Persistent Tic Disorders (PTDs), including Tourette's Disorder (TD); and assesses the effects of wearable short wavelength light therapy on circadian rhythms and tic symptoms.
Our lead scientists for Tourette Syndrome research studies include Emily J Ricketts, PhD.